Literature DB >> 23394187

Occupational asthma incidence: findings from the behavioral risk factor surveillance system asthma call-back survey--United States, 2006-2009.

Jacek M Mazurek1, Gretchen E Knoeller, Jeanne E Moorman, Eileen Storey.   

Abstract

BACKGROUND: Occupational asthma (OA) is new-onset asthma or the recurrence of previously quiescent asthma caused by workplace exposures.
OBJECTIVE: To estimate the incidence of population-based new-onset OA and the proportion of incident asthma that is work-related.
METHODS: Behavioral Risk Factor Surveillance System and Asthma Call-back Survey data collected from persons aged ≥18 years during 2006-2009 in 38 states and the District of Columbia were analyzed. Incident health professional-diagnosed new-onset OA cases were persons whose asthma was diagnosed for the first time within the past 12 months whose health professional indicated their asthma was related to their work. Incident potential new-onset OA cases were persons with asthma diagnosed within the past 12 months who did not have health professional-diagnosed work-related asthma but described their asthma as caused by workplace exposures. The proportion of incident asthma that is work-related was calculated using the 2006-2008 estimate of adult asthma incidence (3800 per million).
RESULTS: The estimated annual incidence of health professional-diagnosed new-onset OA was 179 (95% CI: 113-245) per million population. For combined health professional-diagnosed and potential new-onset OA the incidence was 692 (95% CI: 532-853) per million population. The proportion of incident asthma among adults that is work-related was 4.7% for health professional-diagnosed new-onset OA and 18.2% for combined health professional-diagnosed and potential new-onset OA.
CONCLUSIONS: New-onset asthma in as many as one of six adult patients might be associated with work. Clinicians should consider the role of occupational exposures when evaluating adults with incident asthma which may uncover opportunities for early intervention and reversal of an otherwise chronic disease.

Entities:  

Mesh:

Year:  2013        PMID: 23394187     DOI: 10.3109/02770903.2013.769267

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  6 in total

Review 1.  Review of Diagnostic Challenges in Occupational Asthma.

Authors:  Jacques A Pralong; Andre Cartier
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

Review 2.  Use of population data for assessing trends in work-related asthma mortality.

Authors:  Jacek M Mazurek; Paul K Henneberger
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-04

3.  Distribution of asthma by occupation: Washington State behavioral risk factor surveillance system data, 2006-2009.

Authors:  Naomi J Anderson; Zihong Joyce Fan; Carolyn Reeb-Whitaker; David K Bonauto; Edmund Rauser
Journal:  J Asthma       Date:  2014-07-15       Impact factor: 2.515

4.  Clinical Importance of Work-Exacerbated Asthma: Findings From a Prospective Asthma Cohort in a Highly Industrialized City in Korea.

Authors:  Woori Jo; Kwang Won Seo; Hwa Sik Jung; Chui Yong Park; Byung Ju Kang; Hyeon Hui Kang; Seung Won Ra; Yangjin Jegal; Jong Joon Ahn; Soon Eun Park; Moon Sik Jung; Ju Ik Park; Eun Ji Park; Chang Sun Sim; Tae Bum Kim; Taehoon Lee
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

5.  Setting Occupational Exposure Limits for Chemical Allergens--Understanding the Challenges.

Authors:  G S Dotson; A Maier; P D Siegel; S E Anderson; B J Green; A B Stefaniak; C D Codispoti; I Kimber
Journal:  J Occup Environ Hyg       Date:  2015       Impact factor: 2.155

Review 6.  Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia.

Authors:  Ryan Hoy; Jonathan Burdon; Ling Chen; Susan Miles; Jennifer L Perret; Shivonne Prasad; Naghmeh Radhakrishna; Janet Rimmer; Malcolm R Sim; Deborah Yates; Graeme Zosky
Journal:  Respirology       Date:  2020-10-05       Impact factor: 6.424

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.